chr5-170262707-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005565.5(LCP2):c.854C>T(p.Pro285Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005565.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCP2 | NM_005565.5 | c.854C>T | p.Pro285Leu | missense_variant | 13/21 | ENST00000046794.10 | NP_005556.1 | |
LCP2 | XM_047417171.1 | c.623C>T | p.Pro208Leu | missense_variant | 11/19 | XP_047273127.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCP2 | ENST00000046794.10 | c.854C>T | p.Pro285Leu | missense_variant | 13/21 | 1 | NM_005565.5 | ENSP00000046794 | P1 | |
LCP2 | ENST00000521416.5 | c.239C>T | p.Pro80Leu | missense_variant | 5/13 | 2 | ENSP00000428871 | |||
LCP2 | ENST00000520344.1 | c.155C>T | p.Pro52Leu | missense_variant | 4/8 | 5 | ENSP00000430391 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000177 AC: 44AN: 249174Hom.: 0 AF XY: 0.000178 AC XY: 24AN XY: 135188
GnomAD4 exome AF: 0.0000787 AC: 115AN: 1461676Hom.: 0 Cov.: 32 AF XY: 0.0000839 AC XY: 61AN XY: 727126
GnomAD4 genome AF: 0.000105 AC: 16AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2023 | The c.854C>T (p.P285L) alteration is located in exon 13 (coding exon 13) of the LCP2 gene. This alteration results from a C to T substitution at nucleotide position 854, causing the proline (P) at amino acid position 285 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at